Dana-Farber Cancer Institute appoints executive vice president
Click Here to Manage Email Alerts
James Terwilliger has been appointed executive vice president and chief operating officer at Dana-Farber Cancer Institute.
His appointment will be effective Feb. 18.
Terwilliger currently serves as vice president of clinical services at Montefiore Medical Center in New York.
In that role, he is responsible for faculty and community physician practices, including operations, strategy, practice acquisitions, revenue cycle, and program growth and development.
“Jim has had a proven track record of thoughtful analysis, strategic vision, leadership and the ability to build relationships to inspire greater collaboration,” Laurie H. Glimcher, MD, president and CEO of Dana-Farber Cancer Institute, said in a press release. “His deep personal commitment to quality and compassionate care of patients, and to the science of discovery and innovation will be a great fit for Dana-Farber.”
Terwilliger has led operations at several academic medical centers. He served as executive vice president of UPMC Cancer Center and vice president of cancer services at Indiana University Health. He also has worked with USC University Hospital and UCLA Health System.
“I am honored by the opportunity to join Dr. Glimcher’s leadership team and to work alongside the dedicated physicians, scientists, nurses and clinicians and staff who make Dana-Farber one of the most respected institutions in medicine and science,” Terwilliger said in the release. “Their work helps people who need the best possible cancer care today, but also promises a better future for cancer patients in New England and around the country and the world.”
Terwilliger will succeed Dorothy Puhy, who will retire in late February after spending 25 years in various roles at Dana-Farber.